| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$15,422,350 |
|
|
|
Indirect Value
|
$14,805,518 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$30,227,868 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -83.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-07-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(306) |
6,441,480 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-11-15 |
4 |
B |
$6.90 |
$6,897 |
D/D |
1,000 |
844,450 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-09-30 |
4 |
A |
$1.13 |
$1,130 |
D/D |
1,000 |
887,630 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$6.00 |
$6,000 |
D/D |
1,000 |
888,630 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
S |
$3.06 |
$11,252 |
I/I |
(3,677) |
5,922,207 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2008-03-30 |
5 |
A |
$0.43 |
$2,021 |
I/I |
4,700 |
127,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-07-10 |
4 |
AS |
$3.00 |
$15,000 |
D/D |
(5,000) |
4,217,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-22 |
4 |
AS |
$3.52 |
$17,600 |
D/D |
(5,000) |
6,311,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-23 |
4 |
AS |
$3.95 |
$19,750 |
D/D |
(5,000) |
6,306,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,100 |
31,100 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2011-03-31 |
4 |
A |
$1.08 |
$5,975 |
I/I |
5,532 |
173,232 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2008-09-30 |
5 |
A |
$0.20 |
$1,200 |
I/I |
6,000 |
133,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-03-31 |
4 |
A |
$0.22 |
$1,320 |
I/I |
6,000 |
139,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-03-31 |
4 |
A |
$0.44 |
$2,640 |
I/I |
6,000 |
151,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-09-30 |
5 |
A |
$0.79 |
$4,740 |
I/I |
6,000 |
167,700 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-09-30 |
4 |
A |
$1.00 |
$6,000 |
I/I |
6,000 |
179,232 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
• • • |
2003-10-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,100 |
4,854,768 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-26 |
4 |
AS |
$4.47 |
$33,525 |
D/D |
(7,500) |
6,298,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-04 |
4 |
S |
$5.13 |
$41,517 |
I/I |
(8,093) |
3,119,786 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-05-03 |
4 |
AS |
$3.25 |
$29,250 |
D/D |
(9,000) |
0 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2006-07-07 |
4 |
AS |
$2.65 |
$26,500 |
D/D |
(10,000) |
4,222,268 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-01-04 |
4 |
AS |
$2.23 |
$22,300 |
D/D |
(10,000) |
6,346,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-02-02 |
4 |
AS |
$2.04 |
$20,400 |
D/D |
(10,000) |
6,336,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-03-01 |
4 |
AS |
$2.31 |
$23,100 |
D/D |
(10,000) |
6,326,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-28 |
4/A |
AS |
$5.02 |
$50,200 |
D/D |
(10,000) |
6,288,940 |
0 |
- |
|
107 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
